Skip to main content

MW 550.7 Da, Purity >98%. Novel, cell permeable Hedgehog signaling pathway antagonist (IC50 = 100-200 nM). Selectively binds to smoothened (Smo) (Ki = 44 nM). Blocks the formation of and induces the regression of basaloid lesions in skin punches and shrinks UV-induced basaloid lesions in adult mouse skin. Inhibits proliferation and induces apoptosis in tumor cells without affecting non-tumor cells.

Be the first to review this product! Submit a review

Key facts

CAS number
334998-36-6
Purity
> 98%
Form
Solid
Molecular weight
550.7 Da
Molecular formula
C31H42N4O5
PubChem identifier
10392802
Nature
Synthetic

Alternative names

Recommended products

MW 550.7 Da, Purity >98%. Novel, cell permeable Hedgehog signaling pathway antagonist (IC50 = 100-200 nM). Selectively binds to smoothened (Smo) (Ki = 44 nM). Blocks the formation of and induces the regression of basaloid lesions in skin punches and shrinks UV-induced basaloid lesions in adult mouse skin. Inhibits proliferation and induces apoptosis in tumor cells without affecting non-tumor cells.

Key facts

Purity
> 98%
PubChem identifier
10392802
Solubility

Soluble in DMSO to 70 mM.

Soluble in ethanol to 30 mM.

Biochemical name
N-((3S,5S)-1-(Benzo[d][1,3]dioxol-5-ylmethyl)-5-(piperazine-1-carbonyl)pyrrolidin-3-yl)-N-(3-methoxybenzyl)-3,3-dimethylbutanamide
Biological description

Novel, cell permeable Hedgehog signaling pathway antagonist (IC50 = 100-200 nM). Selectively binds to smoothened (Smo) (Ki = 44 nM). Blocks the formation of and induces the regression of basaloid lesions in skin punches and shrinks UV-induced basaloid lesions in adult mouse skin. Inhibits proliferation and induces apoptosis in tumor cells without affecting non-tumor cells.

Canonical SMILES
CC(C)(C)CC(=O)N(CC1=CC(=CC=C1)OC)C2CC(N(C2)CC3=CC4=C(C=C3)OCO4)C(=O)N5CCNCC5
Isomeric SMILES
CC(C)(C)CC(=O)N(CC1=CC(=CC=C1)OC)[C@H]2C[C@H](N(C2)CC3=CC4=C(C=C3)OCO4)C(=O)N5CCNCC5
InChI
InChI=1S/C31H42N4O5/c1-31(2,3)17-29(36)35(19-22-6-5-7-25(14-22)38-4)24-16-26(30(37)33-12-10-32-11-13-33)34(20-24)18-23-8-9-27-28(15-23)40-21-39-27/h5-9,14-15,24,26,32H,10-13,16-21H2,1-4H3/t24-,26-/m0/s1
InChIKey
WPHXYKUPFJRJDK-AHWVRZQESA-N
IUPAC name
N-[(3S,5S)-1-(1,3-benzodioxol-5-ylmethyl)-5-(piperazine-1-carbonyl)pyrrolidin-3-yl]-N-[(3-methoxyphenyl)methyl]-3,3-dimethylbutanamide

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The Smoothened (SMO) protein also known as Sonic Hedgehog receptor plays a mechanical role in the Hedgehog (Hh) signaling pathway. This protein acts as a transmembrane receptor that transmits signals from the cell surface to the interior. Smoothened has a molecular mass of approximately 86 kDa and is expressed in several tissues including the brain kidney and liver. Its activity requires the presence of another protein Patched which regulates Smoothened by inhibiting or permitting its signaling depending on Hedgehog ligand binding.

Biological function summary

Smoothened is essential for the Hh signaling pathway which is pivotal for embryonic development and tissue regeneration. In this context Smoothened participates in a complex that includes Patched and Gli family transcription factors. This complex orchestrates the transcription of target genes necessary for cellular proliferation differentiation and tissue organization. Smoothened’s role in activating transcription factors makes it integral to modulating gene expression in response to external Hh signals.

Pathways

Smoothened is a central component of the Hedgehog signaling pathway which plays an important role in cell differentiation and organogenesis. Two of the significant pathways it influences are the Sonic Hedgehog (Shh) and Indian Hedgehog (Ihh) signaling pathways. Within these pathways Smoothened interacts closely with the protein Patched which inhibits Smoothened in the absence of Hedgehog ligands. The downstream activation of Smoothened results in the modulation of Gli transcription factors altering the expression of various developmental genes.

Associated diseases and disorders

Smoothened is closely linked to conditions such as basal cell carcinoma and medulloblastoma. Dysregulation or mutations in Smoothened can lead to aberrant activation of Hedgehog signaling contributing to the development and progression of these cancers. The protein Gli as part of the same signaling cascade is also heavily involved in the transcriptional changes associated with these disorders. Inhibitors like Cyclopamine sometimes in an ethanol solution target Smoothened to mitigate its pathological signaling and offer therapeutic approaches for these types of cancers.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

0 product images

    Downloads

    Product protocols

    For this product, it's our understanding that no specific protocols are required. You can:

    Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

    For licensing inquiries, please contact partnerships@abcam.com